Literature DB >> 12022937

Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment.

C Hyde1, B Wake, S Bryan, P Barton, A Fry-Smith, C Davenport, F Song.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12022937     DOI: 10.3310/hta6020

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN: 1366-5278            Impact factor:   4.014


× No keyword cloud information.
  1 in total

1.  Population preference values for treatment outcomes in chronic lymphocytic leukaemia: a cross-sectional utility study.

Authors:  Kathleen M Beusterien; John Davies; Michael Leach; David Meiklejohn; Jessica L Grinspan; Alison O'Toole; Steve Bramham-Jones
Journal:  Health Qual Life Outcomes       Date:  2010-05-18       Impact factor: 3.186

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.